THE DIABETES PREVENTION PROGRAM RESEARCH GROUP* - PowerPoint PPT Presentation

Loading...

PPT – THE DIABETES PREVENTION PROGRAM RESEARCH GROUP* PowerPoint presentation | free to download - id: 4573d2-NTY0Z



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*

Description:

THE DIABETES PREVENTION PROGRAM RESEARCH GROUP* Diabetes Care Volume 35: 723-730 April, 2012 Featured Article: The 10-Year Cost-Effectiveness of Lifestyle ... – PowerPoint PPT presentation

Number of Views:152
Avg rating:3.0/5.0
Slides: 9
Provided by: Cristina103
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*


1
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP
Diabetes Care Volume 35 723-730 April, 2012
2
Study Objective
  •  
  • Diabetes Prevention Program (DPP) and its
    Outcomes Study (DPPOS) demonstrated that either
    intensive lifestyle intervention or metformin
    could prevent type 2 diabetes in high-risk adults
    for at least 10 years after randomization
  •  
  • Study reports 10-year within-trial
    cost-effectiveness of the interventions
  •  

THE DIABETES PREVENTION PROGRAM RESEARCH GROUP
et al. Diabetes Care 201235723-730
3
Study Design
  • Data on resource utilization, cost, and quality
    of life collected prospectively
  •  
  • Economic analyses were performed from health
    system and societal perspectives

THE DIABETES PREVENTION PROGRAM RESEARCH GROUP
et al. Diabetes Care 201235723-730
4
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP
et al. Diabetes Care 201235723-730
5
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP
et al. Diabetes Care 201235723-730
6
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP
et al. Diabetes Care 201235723-730
7
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP
et al. Diabetes Care 201235723-730
8
Conclusions
  •  
  • Over 10 years, from a payer perspective,
    lifestyle was cost-effective and metformin was
    marginally cost-saving compared with placebo
  •  
  • Investment in lifestyle and metformin
    interventions for diabetes prevention in
    high-risk adults provides good value for the
    money spent

THE DIABETES PREVENTION PROGRAM RESEARCH GROUP
et al. Diabetes Care 201235723-730
About PowerShow.com